Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model.

McCrone P, Fisher H, Knight C, Harding R, Schlag AK, Nutt DJ, Neill JC

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (0)

No references identified in the available metadata. This does not establish that none exist.

    Cited by — these papers cite this paper (9)

    1. Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression 2026-11-01 · Expand citations
    2. Efficacy and safety of psilocybin-assisted therapy for alcohol use disorder: A systematic review and meta-analysis 2026-10-08 · Expand citations
    3. Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview 2026-07-13 · Expand citations
    4. Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World Implementation 2026-06-03 · Expand citations
    5. Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations 2026-06-01 · Expand citations
    6. Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial 2026-05-27 · Expand citations
    7. Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applications 2026-03-01 · Expand citations
    8. PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION 2026-01-28 · Expand citations
    9. Therapeutic Implications of Psilocybin in the Wake of Decriminalization 2024-06-01 · Expand citations